by Stacey Johnson | Jun 24, 2025
Pink. What does the colour pink make you think of? It might make you think of activism, acceptance, awareness and allyship based on how it has been adopted by various groups around the world. Pink makes me think of the American singer, songwriter and activist P!nk....
by Krystal Jacques | May 29, 2025
Imagine a one-and-done treatment for stroke using the regenerative capacity of your brain. Tianhao Chen, Dr. Cindi Morshead’s lab, and Dr. Hani E. Naguib’s lab have developed a biodegradable electrode that can electrically stimulate neural precursor cells (NPCs). This...
by Kevin Robb | May 22, 2025
For the first time, mesenchymal stromal cells (MSCs) can be used in routine clinical practice under the nod of regulatory approval in the United States. The MSC product known as Ryoncil was made available to patients in March 2025 following a historic decision from...
by Lyla El-Fayomi | May 16, 2025
In this edition of RMNU🔬, we’re keeping up with multiple research advances in the vision repair field. Also, Vertex Pharmaceuticals is dropping a big therapeutic from their portfolio, and Longeveron has a new publication. Of course, yet another round of updates on...
by Lyla El-Fayomi | Apr 16, 2025
A brief recap You might recall Johanne Provost’s story, which I covered in the September edition of RMNU🔬. New details have since emerged regarding the specifics of her disease: Ms. Provost had been suffering from a rare autoimmune disease – lichen planus – that...
by Lyla El-Fayomi | Mar 26, 2025
Some big trends to discuss this month, as well as one-off headlines. I have clinical updates on epilepsy, tooth regeneration and Parkinson’s – a disease area quickly becoming an RMNU🔬 staple, given all the movement in this field! Read on, bookmark for later, or send...
Comments